Fig. 2From: The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trialsA Six-week stability (T1 to T2) in the ASD group; B T1 ASD vs. TD boxplots; and C T1 ASD versus TD histograms for Oculomotor Index of Gaze to Human Faces (OMI), Biomotion (BM) %Bio, and PLR Latency Biomarkers. Diagonal line in stability charts is identity (slope = 1). See Supplemental Figures S2-S3 for additional biomarkersBack to article page